MobileMedMinder: A Networked Aide for Medication Compliance

在该项目的第一阶段（SBIR PHS 2008-1，“测量和增强药物依从性的方法学开发，主题33），MobileMedMinder得到了成功演示。第二阶段将涉及合作开发和商业化MobileMedMinder。该产品将允许用户使用现有的移动的设备注册和验证药物摄入量，并通过无线连接无障碍地链接到网络。 MobileMedMinder将提供以下功能：1）通过Medscanning、电子选择列表、语音识别自动或半自动输入药物信息。2)与在线服务器进行实时通信，可以监控药物，并直接或通过社交网络解决方案从自动化系统，护理人员或医生那里提出建议。3)如果成功，MobileMedMinder可以扩展为一个移动的平台，用于慢性病管理系统，如糖尿病、抑郁症、高血压等。 计划在俄亥俄州州立大学医学中心进行以用户为中心的可用性测试和主题研究，以提供全面、非侵入性、便携式解决方案，支持药物依从性。最终目标是开发一种产品，供患者在移动的/网络平台上使用，以促进药物依从性和行为改变，随后可以商业化。

Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product will allow users to enroll and verify medication intake using the existing mobile devices, and link seemlessly to the web through a wireless connection. MobileMedMinder will provide the following: 1) automatic or semi-automatic entry of medication information through Medscanning, electronic pick lists, voice recognition. 2) Real-time communication with an on-line server where medication can be monitored and recommendations made from automated systems, caregivers or physicians directly or through social networking solutions. 3) If successful, MobileMedMinder can be extended as a mobile platform for chronic disease management system, such as diabetes, depression, hypertension, etc. A user-centered usability testing and subject study at the Ohio State University Medical Center is planned to provide a comprehensive, non-intrusive, portable solution in support of medication compliance. The ultimate goal is to develop a product for use by patients on a mobile/web platform to promote medication compliance and behavior change that can be subsequently commercialized.